Deutsche Bank Aktiengesellschaft Reiterates Buy Rating for ConvaTec Group (LON:CTEC)

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reaffirmed by equities researchers at Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Thursday, MarketBeat reports. They presently have a GBX 315 ($4.30) price objective on the stock. Deutsche Bank Aktiengesellschaft’s target price would suggest a potential upside of 18.69% from the stock’s previous close.

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 310 ($4.23) price objective on shares of ConvaTec Group in a report on Wednesday, March 5th.

ConvaTec Group Stock Performance

LON:CTEC opened at GBX 265.40 ($3.62) on Thursday. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. The firm has a market capitalization of £6.75 billion, a price-to-earnings ratio of 44.70, a PEG ratio of 0.93 and a beta of 0.64. The firm’s fifty day simple moving average is GBX 277.82 and its 200 day simple moving average is GBX 255.81. ConvaTec Group has a twelve month low of GBX 211.80 ($2.89) and a twelve month high of GBX 311.20 ($4.25).

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.